TTYA01

N/A

Report date: 2024/12/18 14:09:11

Base Information

Drug NameTTYA01
Drug Alias NameTTYA01
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein > Fc fusion protein
Mechanisms of ActionLow affinity neurotrophin receptor p75NTR modulators
TargetsLow affinity neurotrophin receptor p75NTR
Therapy Area/IndicationsPlaque psoriasisArthritis, RheumatoidSpondylitis, Ankylosing
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesShanghai Auzone Biological Technology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShanghai Auzone Biological Technology Co Ltd
Inactive CompaniesN/A
Active IndicationsPlaque psoriasisArthritis, RheumatoidSpondylitis, Ankylosing
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A